Your browser doesn't support javascript.
loading
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Gaba, Prakriti; Bhatt, Deepak L; Steg, Ph Gabriel; Miller, Michael; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Juliano, Rebecca A; Jiao, Lixia; Doyle, Ralph T; Granowitz, Craig; Tardif, Jean-Claude; Giugliano, Robert P; Martens, Fabrice M A C; Gibson, C Michael; Ballantyne, Christie M.
Affiliation
  • Gaba P; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Bhatt DL; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: DLBhattMD@post.Harvard.edu.
  • Steg PG; Université de Paris, FACT (French Alliance for Cardiovascular Trials), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, INSERM Unité 1148, Paris, France.
  • Miller M; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Brinton EA; Utah Lipid Center, Salt Lake City, Utah, USA.
  • Jacobson TA; Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Ketchum SB; Amarin Pharma, Inc (Amarin), Bridgewater, New Jersey, USA.
  • Juliano RA; Amarin Pharma, Inc (Amarin), Bridgewater, New Jersey, USA.
  • Jiao L; Amarin Pharma, Inc (Amarin), Bridgewater, New Jersey, USA.
  • Doyle RT; Amarin Pharma, Inc (Amarin), Bridgewater, New Jersey, USA.
  • Granowitz C; Amarin Pharma, Inc (Amarin), Bridgewater, New Jersey, USA.
  • Tardif JC; Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
  • Giugliano RP; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Martens FMAC; Werkgroep Cardiologische centra Nederland (WCN: Dutch Network for Cardiovascular Research) and the Department of Cardiology, Deventer Hospital, Deventer, the Netherlands.
  • Gibson CM; Department of Cardiovascular Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Ballantyne CM; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
J Am Coll Cardiol ; 79(17): 1660-1671, 2022 05 03.
Article in En | MEDLINE | ID: mdl-35483753
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertriglyceridemia / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Stroke / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertriglyceridemia / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Stroke / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2022 Document type: Article Affiliation country: United States